MedPath

Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology logo
🇺🇸United States
Ownership
Private
Established
2011-01-01
Employees
251
Market Cap
-
Website
https://www.allianceforclinicaltrialsinoncology.org

Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2004-07-22
Last Posted Date
2016-07-20
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
75
Registration Number
NCT00003812
Locations
🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

🇺🇸

Rhode Island Hospital, Providence, Rhode Island, United States

🇺🇸

University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States

and more 45 locations

Topotecan in Treating Patients With Myelodysplastic Syndrome

Phase 2
Completed
Conditions
Leukemia
Myelodysplastic Syndromes
Interventions
First Posted Date
2004-07-22
Last Posted Date
2016-07-20
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
100
Registration Number
NCT00003675
Locations
🇺🇸

Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, United States

🇺🇸

University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States

🇺🇸

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States

and more 45 locations

Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy

Phase 3
Completed
Conditions
Head and Neck Cancer
Radiation Toxicity
Interventions
Other: placebo
Dietary Supplement: capsaicin
Radiation: radiation therapy
First Posted Date
2004-07-22
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
18
Registration Number
NCT00003610
Locations
🇺🇸

CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States

🇺🇸

CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States

🇺🇸

CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States

and more 14 locations

Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer

Phase 3
Completed
Conditions
Prostate Cancer
Interventions
Drug: ketoconazole
Other: Withdrawal of antiandrogen therapy
Drug: therapeutic hydrocortisone
First Posted Date
2004-07-19
Last Posted Date
2016-06-28
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
260
Registration Number
NCT00002760
Locations
🇺🇸

UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States

🇺🇸

University of Minnesota Cancer Center, Minneapolis, Minnesota, United States

Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2004-07-19
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
59
Registration Number
NCT00002998
Locations
🇺🇸

CCOP - Carle Cancer Center, Urbana, Illinois, United States

🇺🇸

Siouxland Hematology-Oncology, Sioux City, Iowa, United States

🇺🇸

CentraCare Clinic, Saint Cloud, Minnesota, United States

and more 17 locations

Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
Biological: interleukin 2
Biological: rhuMAb
First Posted Date
2004-07-19
Last Posted Date
2016-06-28
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
355
Registration Number
NCT00002994
Locations
🇺🇸

University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States

🇺🇸

North Shore University Hospital, Manhasset, New York, United States

🇺🇸

Vermont Cancer Center, Burlington, Vermont, United States

and more 31 locations

Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Lymphoma
Interventions
Drug: doxorubicin hydrochloride
Drug: gemcitabine hydrochloride
Drug: vinblastine
Procedure: fludeoxyglucose F 18 positron-emission tomography (PET) scan
Procedure: CT scan
First Posted Date
2004-07-12
Last Posted Date
2016-07-01
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
104
Registration Number
NCT00086801
Locations
🇺🇸

Memorial Hospital of South Bend, South Bend, Indiana, United States

🇺🇸

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States

🇺🇸

Beebe Medical Center, Lewes, Delaware, United States

and more 44 locations

Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy

Phase 3
Completed
Conditions
Breast Cancer
Hot Flashes
Interventions
Drug: gabapentin
Drug: antidepressant
First Posted Date
2004-07-12
Last Posted Date
2016-07-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
118
Registration Number
NCT00087399
Locations
🇺🇸

Bismarck Cancer Center, Bismarck, North Dakota, United States

🇺🇸

John and Dorothy Morgan Cancer Center at Lehigh Valley Hospital, Allentown, Pennsylvania, United States

🇺🇸

Galesburg Clinic, Galesburg, Illinois, United States

and more 159 locations

Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2004-06-24
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
106
Registration Number
NCT00003762
Locations
🇺🇸

CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States

🇺🇸

CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States

🇺🇸

CCOP - Geisinger Clinical and Medical Center, Danville, Pennsylvania, United States

and more 14 locations

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Phase 3
Completed
Conditions
Lung Cancer
Interventions
Drug: carboplatin
Drug: paclitaxel
Radiation: radiation therapy
Procedure: surgery
First Posted Date
2004-06-24
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
480
Registration Number
NCT00003317
Locations
🇺🇸

Rapid City Regional Hospital, Rapid City, South Dakota, United States

🇺🇸

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States

🇺🇸

CCOP - Duluth, Duluth, Minnesota, United States

and more 13 locations
© Copyright 2025. All Rights Reserved by MedPath